Bluejay Diagnostics, Inc. Basic Shares Outstanding (Weighted Average)
Bluejay Diagnostics, Inc. (BJDX) reported Basic Shares Outstanding (Weighted Average) of 2.08 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.08M shares, a 499.59% increase year-over-year.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 984.67K shares, a 610.94% increase year-over-year.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -1.72M shares.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.57M shares, a 723.86% increase year-over-year.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 449.04K shares, a 879.42% increase from fiscal 2024.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 45.85K shares, a 1572.67% increase from fiscal 2023.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 2.74K shares, a 99.73% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 1.01M shares, a 88.17% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.08M shares 10-Q · filed 2026-08-12 | 1.53M shares 10-Q · filed 2026-08-12 | 448.15K shares derived: average of 3 quarters · filed 2026-08-12 | 729.74K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 984.67K shares 10-Q · filed 2026-05-07 | -367.41K shares derived: average of 2 quarters · filed 2026-05-07 | 279.90K shares derived: average of 3 quarters · filed 2026-05-07 | 296.62K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -1.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -72.48K shares derived: average of 2 quarters · filed 2026-03-06 | 67.27K shares derived: average of 3 quarters · filed 2026-08-12 | 449.04K shares 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | 1.57M shares 10-Q · filed 2025-11-07 | 960.66K shares derived: average of 2 quarters · filed 2026-08-12 | 1.17M shares 10-Q · filed 2025-11-07 | 509.13K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 346.78K shares 10-Q · filed 2026-08-12 | 1.39M shares 10-Q · filed 2025-08-07 | 242.64K shares 10-Q · filed 2026-08-12 | 970.57K shares 10-Q · filed 2025-08-07 | 154.00K shares derived: average of 3 quarters · filed 2026-08-12 | 163.28K shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | 138.50K shares 10-Q · filed 2026-05-07 | 554.01K shares 10-Q · filed 2025-05-13 | 57.61K shares derived: average of 2 quarters · filed 2026-05-07 | 102.11K shares derived: average of 3 quarters · filed 2026-05-07 | 79.00K shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -23.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 83.92K shares derived: average of 2 quarters · filed 2026-03-06 | 59.16K shares derived: average of 3 quarters · filed 2026-03-06 | 45.85K shares 10-K · filed 2026-03-06 | 183.39K shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 191.12K shares 10-Q · filed 2025-11-07 | 9.56M shares 10-Q · filed 2024-11-07 | 100.39K shares derived: average of 2 quarters · filed 2025-11-07 | 68.89K shares 10-Q · filed 2025-11-07 | 3.44M shares 10-Q · filed 2024-11-07 | -43.88K shares derived: average of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | 9.66K shares 10-Q · filed 2025-08-07 | 483.16K shares 10-Q · filed 2024-08-14 | 7.78K shares 10-Q · filed 2025-08-07 | 389.04K shares 10-Q · filed 2024-08-14 | -122.21K shares derived: average of 3 quarters · filed 2025-08-07 | -57.19K shares derived: average of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | 5.90K shares 10-Q · filed 2025-05-13 | 2.36M shares 10-Q · filed 2024-05-15 | -188.15K shares derived: average of 2 quarters · filed 2025-05-13 | -79.48K shares derived: average of 3 quarters · filed 2025-05-13 | -27.64K shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -382.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -122.16K shares derived: average of 2 quarters · filed 2025-03-31 | -38.82K shares derived: average of 3 quarters · filed 2025-03-31 | 2.74K shares 10-K · filed 2025-03-31 | 1.10M shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 137.87K shares 10-Q · filed 2024-11-07 | 1.10M shares 10-Q · filed 2023-11-09 | 132.88K shares derived: average of 2 quarters · filed 2024-11-07 | 131.05K shares 10-Q · filed 2024-11-07 | 1.05M shares 10-Q · filed 2023-11-09 | 573.74K shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 127.88K shares 10-Q · filed 2024-08-14 | 1.02M shares 10-Q · filed 2023-08-14 | 127.61K shares 10-Q · filed 2024-08-14 | 1.02M shares 10-Q · filed 2023-08-14 | 719.03K shares derived: average of 3 quarters · filed 2024-08-14 | 791.18K shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 1.02M shares 10-Q · filed 2024-05-15 | 20.38M shares 10-Q · filed 2023-05-11 | 1.01M shares derived: average of 2 quarters · filed 2024-05-15 | 1.01M shares derived: average of 3 quarters · filed 2024-05-15 | 1.01M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 1.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 1.01M shares derived: average of 2 quarters · filed 2024-03-28 | 1.01M shares derived: average of 3 quarters · filed 2024-03-28 | 1.01M shares 10-K · filed 2024-03-28 | 20.16M shares 10-K · filed 2023-03-20 | |||
| 2022-09-30 | 1.01M shares 10-Q · filed 2023-11-09 | 20.15M shares 10-Q · filed 2022-11-09 | 1.01M shares derived: average of 2 quarters · filed 2023-11-09 | 1.01M shares 10-Q · filed 2023-11-09 | 20.15M shares 10-Q · filed 2022-11-09 | 9.32M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 1.01M shares 10-Q · filed 2023-08-14 | 20.15M shares 10-Q · filed 2022-08-10 | 1.01M shares 10-Q · filed 2023-08-14 | 20.15M shares 10-Q · filed 2022-08-10 | 12.09M shares derived: average of 3 quarters · filed 2023-08-14 | 11.69M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 20.14M shares 10-Q · filed 2023-05-11 | 17.63M shares derived: average of 2 quarters · filed 2023-05-11 | 15.25M shares derived: average of 3 quarters · filed 2023-05-11 | 12.49M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 15.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 12.81M shares derived: average of 2 quarters · filed 2023-03-20 | 9.94M shares derived: average of 3 quarters · filed 2023-03-20 | 8.52M shares 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | 10.49M shares 10-Q · filed 2022-11-09 | 7.35M shares derived: average of 2 quarters · filed 2022-11-09 | 6.32M shares 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | 4.20M shares 10-Q · filed 2022-08-10 | 4.20M shares 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |